SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-24-027164
Filing Date
2024-06-07
Accepted
2024-06-07 07:01:10
Documents
7
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre14a2024.htm PRE 14A 3050914
2 GRAPHIC avalo-logoxblk.jpg GRAPHIC 48586
3 GRAPHIC avalotherapeuticsinc_vxp001.jpg GRAPHIC 155237
4 GRAPHIC avalotherapeuticsinc_vxp002.jpg GRAPHIC 112777
5 GRAPHIC capnetloss_2023xv4.jpg GRAPHIC 75638
6 GRAPHIC captsr_2024xv4.jpg GRAPHIC 68739
7 GRAPHIC investordeck_pipelinechart.jpg GRAPHIC 492886
  Complete submission text file 0001628280-24-027164.txt   4363574
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37590 | Film No.: 241027254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)